XML 52 R40.htm IDEA: XBRL DOCUMENT v3.19.1
AbbVie Collaboration Agreement - Additional Information (Detail)
$ in Thousands
1 Months Ended 3 Months Ended
Dec. 18, 2018
USD ($)
Sep. 27, 2018
USD ($)
Milestone
May 31, 2017
USD ($)
Dec. 31, 2015
USD ($)
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Feb. 28, 2019
USD ($)
Dec. 31, 2018
USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Recognition of revenue         $ 338 $ 354    
Long term deferred revenue         465      
Current deferred revenue         1,964     $ 268
AbbVie Agreement                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Number of mile stone payments under second phase | Milestone   2            
Initial milestone payment upon execution of amendment   $ 2,000            
Increase in transaction price of performance obligation of second phase $ 2,000              
Remaining milestone achieved             $ 2,500  
Recognition of revenue         300 $ 400    
Long term deferred revenue         2,000      
Current deferred revenue         500      
AbbVie Agreement | IBDCo                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Upfront non refundable payment       $ 2,000        
Potential milestone payment         $ 16,500      
Collaboration in research and development         54 months      
Milestone payment     $ 2,000